Adapting effective mHealth interventions to improve uptake and adherence of the HIV pre-exposure prophylaxis (PrEP) in Thai young Men who have Sex with Men

Institute of HIV Research and Innovation0 sites170 target enrollmentSeptember 16, 2021

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: HIV-uninfected young MSM at risk for acquiring HIV infection, ages 16 to 29 years.
Sponsor: Institute of HIV Research and Innovation
Enrollment: 170
Status: Not yet recruiting
Last Updated: last year

No summary available.

Registry

who.int

Start Date

September 16, 2021

End Date

September 30, 2023

Last Updated

last year

Study Type

Interventional

Sex

Male

Sponsor

Institute of HIV Research and Innovation

•1\) age 16\-29 years
•2\) men who report sex with men in the past 12 months
•3\) laboratory confirmed HIV negative status
•4\) self\-reported evidence of being at\-risk for HIV acquisition, including one of the following in the past 6 months: having a sex with an HIV\-positive partner, having anal sex without using a condom, being diagnosed with an STI, or having any illicit drug use (e.g., Amphetamine type stimulants)
•5\) able to understand, read and speak Thai
•6\) either having not started PrEP (Group 1: PrEP naive) or currently on PrEP but not adherent to PrEP (taking 3 pills/week) in the past month (Group 2: PrEP users)

•1\) in a mutually monogamous relationship of \> 6 months with a partner who recently tested HIV\-negative
•2\) a serious cognitive or psychiatric problem that would compromise ability to provide informed consent
•3\) currently enrolled in another HIV intervention study.